SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  2. 2
    Masataka Tsuge, Eisuke Murakami, Michio Imamura, Hiromi Abe, Daiki Miki, Nobuhiko Hiraga, Shoichi Takahashi, Hidenori Ochi, C. Nelson Hayes, Hiroyuki Ginba, Kazuhiro Matsuyama, Hiroiku Kawakami, Kazuaki Chayama, Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients, Journal of Gastroenterology, 2013, 48, 10, 1188

    CrossRef

  3. 3
    Soon Sun Kim, Jae Youn Cheong, Dami Lee, Myoung Hee Lee, Sun Pyo Hong, Soo-Ok Kim, Sung Won Cho, Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B, Journal of Medical Virology, 2012, 84, 1
  4. 4
    Hyo-Joon Yang, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance, Journal of Medical Virology, 2012, 84, 3
  5. 5
    KASL Clinical Practice Guidelines: Management of chronic hepatitis B, Clinical and Molecular Hepatology, 2012, 18, 2, 109

    CrossRef

  6. 6
    Waka Ohishi, Kazuaki Chayama, Treatment of chronic hepatitis B with nucleos(t)ide analogues, Hepatology Research, 2012, 42, 3
  7. 7
    Lynne Strasfeld, Sunwen Chou, Antiviral Drug Resistance: Mechanisms and Clinical Implications, Infectious Disease Clinics of North America, 2010, 24, 3, 809

    CrossRef

  8. 8
    Lynne Strasfeld, Sunwen Chou, Antiviral Drug Resistance: Mechanisms and Clinical Implications, Infectious Disease Clinics of North America, 2010, 24, 2, 413

    CrossRef

  9. 9
    Feifei Wang, Honghai Wang, Hongbo Shen, Chengyan Meng, Xinhua Weng, Wenhong Zhang, Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues, Clinical Therapeutics, 2009, 31, 2, 360

    CrossRef

  10. 10
    Mari Inada, Osamu Yokosuka, Current antiviral therapies for chronic hepatitis B, Hepatology Research, 2008, 38, 6